Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Biome Australia Ltd ( (AU:BIO) ) has shared an update.
Biome Australia Limited has announced a Quarterly Results webinar scheduled for October 23, 2025, where the company’s Managing Director, Blair Vega Norfolk, will provide an update on the company’s quarterly performance. This event is an opportunity for investors to engage with the company and gain insights into its operations and market positioning, potentially impacting stakeholder perspectives and investment decisions.
The most recent analyst rating on (AU:BIO) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Biome Australia Ltd stock, see the AU:BIO Stock Forecast page.
More about Biome Australia Ltd
Biome Australia Limited is a microbiome health company that develops, licenses, commercializes, and markets innovative, evidence-based live biotherapeutics (probiotics) and complementary medicines. The company focuses on improving health outcomes and quality of life through products accessible via professional health channels. Incorporated in 2018, Biome partners with leading microbiome research organizations to produce unique live biotherapeutic products, such as the Activated Probiotics® range, which are supported by clinical research and trials.
Average Trading Volume: 360,091
Technical Sentiment Signal: Sell
See more insights into BIO stock on TipRanks’ Stock Analysis page.